Skip to main content

Table 1 Dietary FA compositions

From: A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet

Ingredient (%) Control chow CDAA-HF-T(+) CDAA-HF-T(−)
C14:0 0.5 0.3 0.8
C16:0 11.4 13.2 26.1
C16:1 n-7 0.7 0.1 0.2
C18:0 1.1 6.0 4.2
C18:1 n-7 1.6 10.6 0.9
C18:1 n-7 t 0.1 7.2 0.0
C18:1 n-9 23.2 32.6 43.0
C18:1 n-9 t 0.1 3.4 0.1
C18:2 n-6 52.1 25.0 23.8
C18:2 n-6 tt N.D. 0.6 0.0
C18:3 n-3 3.4 0.4 0.4
C18:3 n-6 N.D. 0.2 0.1
C20:0 0.3 0.4 0.4
C20:2 n-6 0.0 0.0 0.0
C20:3 n-6 N.D. N.D. N.D.
C20:4 n-6 N.D. 0.0 N.D.
C20:5 n-3 1.2 N.D. N.D.
C22:5 n-3 0.1 N.D. N.D.
C22:6 n-3 4.2 N.D. N.D.
Total 100 100 100
Ingredient (%) Control chow CDAA-HF-T(+) CDAA-HF-T(−)
SFA 13.2 19.9 31.5
MUFA 25.5 43.3 44.0
n-6 PUFA 52.2 25.1 23.9
n-3 PUFA 8.9 0.4 0.4
TFAs 0.2 11.2 0.2
Total 100 100 100
Total fat (g/100 g diet) Control chow CDAA-HF-T(+) CDAA-HF-T(−)
  4.5 24.5 24.5
  1. ND not detected
\